the dhitiomics team · 2017-02-08 · the dhitiomics team dr. sudha rao, ph.d. founder &...

4

Upload: others

Post on 07-Jul-2020

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: THE DHITIOMICS TEAM · 2017-02-08 · THE DHITIOMICS TEAM Dr. Sudha Rao, Ph.D. Founder & Director Mr. Kannan Ramesh Co-Founder & Director Dr. Honey Reddi, Ph.D., FACMG. Consultant,

THEDHITIOMICS TEAM

Dr. Sudha Rao, Ph.D. Founder & Director

Mr. Kannan Ramesh Co-Founder & Director

Dr. Honey Reddi, Ph.D., FACMG. Consultant, Clinical Genetics

Ms. Meena Vaidyanathan Consultant, Brand Management

Ms. Nandita Mullapudi, Ph.D. Laboratory Director

Page 2: THE DHITIOMICS TEAM · 2017-02-08 · THE DHITIOMICS TEAM Dr. Sudha Rao, Ph.D. Founder & Director Mr. Kannan Ramesh Co-Founder & Director Dr. Honey Reddi, Ph.D., FACMG. Consultant,

Dhitiomics Technologies provides molecular diagnostic

services, leveraging experienced researchers and experts

in the eld of genomics, healthcare and technology. The

team at Dhitiomics Technologies aims to provide deeper

insight into diagnosis for rare and difficult diseases

through clinical genomics collaborating with subject

matter experts. This can help clinicians predict, prevent

andand pre-empt diseases better enable them to make an

informed choice for their patients. Dhitiomics

Technologies is supported by Genomics Labs at Genotypic

Technologies.

Dhitiomics Technologies provides molecular diagnostic

services, leveraging experienced researchers and experts

in the eld of genomics, healthcare and technology. The

team at Dhitiomics Technologies aims to provide deeper

insight into diagnosis for rare and difficult diseases

through clinical genomics collaborating with subject

matter experts. This can help clinicians predict, prevent

andand pre-empt diseases better enable them to make an

informed choice for their patients. Dhitiomics

Technologies is supported by Genomics Labs at Genotypic

Technologies.

- The Dhitiomics team has experienced researchers and subject matter experts in the eld of genomics, healthcare and technology

- The founding team at Dhitiomics also founded India’s rst genomics company

-- Dhitiomics’s collaborative approach towards molecular diagnosis and reporting helps clinicians predict and pre-empt diseases better

- Accessible molecular diagnosis provides patients an opportunity to have a more informed choice of personalised treatment

WHY DHITI?

Page 3: THE DHITIOMICS TEAM · 2017-02-08 · THE DHITIOMICS TEAM Dr. Sudha Rao, Ph.D. Founder & Director Mr. Kannan Ramesh Co-Founder & Director Dr. Honey Reddi, Ph.D., FACMG. Consultant,

SCREENING FOR CARDIOMYOPATHY RISK

PRE-NATAL SCREENING FOR CHROMOSOMAL ABNORMALITIES

SCREENING FOR AUTISM

MUTATION PROFILING FOR SOLID AND OTHER TUMOURS

HIGH RESOLUTION HLA TYPING

Dhitiomics has a comprehensive service portfolio impacting major specialities

Sequencing of 46 genes implicated in inherited cardiomyopathies. (Sample Source – Blood / Saliva) (Test type- NGS)

Microarray or NGS-based screening to detect trisomies in Chromosome 21, 14 and 17. (Sample Source: Fetal DNA) (Test type- Microarray / NGS)

Targets 101 developmental delay genes covering 1728 exons linked speciically to autism spectrum disorders (ASDs). (Sample Source: Blood / Saliva) (Test type- NGS)

Sequencing of mutational hotspots from common oncogenes and tumour suppressors. (Sample Source: Frozen tissue / FFPE samples) (Test type- NGS)

IDENTIFICATION OF MUTATIONS IMPLICATED IN INHERITED DISORDERS

SCANNING THE EXOME FOR DISEASE CAUSING MUTATIONS

Sequencing of mutations in 448 genes implicated in inherited diseases. (Sample Source: Blood / Saliva) (Test type- NGS)

Targets the entire coding region (~5000 clinically relevant genes) of the human genome & identiies variants with known clinical signiicance. (Sample Source: Blood / Saliva) (Test type- NGS)

SCREENING FOR MATURITY ONSET DIABETESRisk pre-disposition testing by sequencing of genes implicated in Maturity - Onset Diabetes. (Sample Source: Blood / Saliva) (Test type- NGS)

MUTATION PROFILING FOR NEURO - MUSCULAR DISORDERS

TECHNOLOGY PLATFORMS ADOPTED

Sequencing of focussed panel of genes implicated in neuro-muscular disorders. (Sample Source: Blood / Saliva) (Test type- NGS)

- Next Generation Sequencing (NGS) by Illumina and Ion platforms- Array CGH on Agilent platforms- Capillary Electrophoresis on ABI3730

IDENTIFICATION OF MUTATIONS IMPLICATED IN INHERITED DISORDERS

SCANNING THE EXOME FOR DISEASE CAUSING MUTATIONS

Sequencing of mutations in 448 genes implicated in inherited diseases. (Sample Source: Blood / Saliva) (Test type- NGS)

Targets the entire coding region (~5000 clinically relevant genes) of the human genome & identiies variants with known clinical signiicance. (Sample Source: Blood / Saliva) (Test type- NGS)

SCREENING FOR MATURITY ONSET DIABETESRisk pre-disposition testing by sequencing of genes implicated in Maturity - Onset Diabetes. (Sample Source: Blood / Saliva) (Test type- NGS)

MUTATION PROFILING FOR NEURO - MUSCULAR DISORDERS

TECHNOLOGY PLATFORMS ADOPTED

Sequencing of focussed panel of genes implicated in neuro-muscular disorders. (Sample Source: Blood / Saliva) (Test type- NGS)

- Next Generation Sequencing (NGS) by Illumina and Ion platforms- Array CGH on Agilent platforms- Capillary Electrophoresis on ABI3730

Page 4: THE DHITIOMICS TEAM · 2017-02-08 · THE DHITIOMICS TEAM Dr. Sudha Rao, Ph.D. Founder & Director Mr. Kannan Ramesh Co-Founder & Director Dr. Honey Reddi, Ph.D., FACMG. Consultant,

Before you undergo genetic testing, gather as much information as you can about your family’s medical history. Consult with your doctor or a genetic counsellor about your personal and family medical history to better understand the treatment options, depending on the results of the test. Your doctor or genetic counsellor is the best placed to take a decision on the need for a genetic diagnostic test.

Check to see if you carry a genetic mutation that increases your risk for a disease, such as breast cancer or huntington’s disease. This may be useful if you have a family history of the disease.

Screen for genetic mutations that may help your clinician diagnose your condition better to prescribe a more personalised treatment.

If you have a family history of a specific/ rare/ incurable diseases, information obtained from this type of testing can help guide a couple to know if they are likely to be carriers of the disease and make decisions regarding pregnancy.

In addition to the the above tests, Dhitiomics is happy to engage in discussions with clinicians, to develop custom assays to address unmet diagnostic needs, for speciic disorders.

Contact us at [email protected] or +91-89712 78811 for more details.

Before you undergo genetic testing, gather as much information as you can about your family’s medical history. Consult with your doctor or a genetic counsellor about your personal and family medical history to better understand the treatment options, depending on the results of the test. Your doctor or genetic counsellor is the best placed to take a decision on the need for a genetic diagnostic test.

Check to see if you carry a genetic mutation that increases your risk for a disease, such as breast cancer or huntington’s disease. This may be useful if you have a family history of the disease.

Screen for genetic mutations that may help your clinician diagnose your condition better to prescribe a more personalised treatment.

If you have a family history of a specific/ rare/ incurable diseases, information obtained from this type of testing can help guide a couple to know if they are likely to be carriers of the disease and make decisions regarding pregnancy.

In addition to the the above tests, Dhitiomics is happy to engage in discussions with clinicians, to develop custom assays to address unmet diagnostic needs, for speciic disorders.

Contact us at [email protected] or +91-89712 78811 for more details.